News Releases

News Releases

Microbix Featured at Cantech Investment Conference
JANUARY 29, 2018

Microbix Featured at Cantech Investment Conference

JANUARY 29, 2018 Angus Gastle

Invited onto Panel about Managing Canadian Healthcare Companies for Growth TORONTO, January 29, 2018 - Microbix Biosystems Inc. (TSX: MBX,...

Read more
Microbix Expands Quality Assessment Product Family
JANUARY 18, 2018

Microbix Expands Quality Assessment Product Family

JANUARY 18, 2018 Angus Gastle

48 New Products Being Added, Under PTDx™ and PROCEEDx™ Brands TORONTO, January 18, 2018 - Microbix Biosystems Inc. (TSX: MBX, Microbix®), ...

Read more
Microbix Reports Full Year and Fourth Quarter Results – Record Sales of $10.2 Million Achieved for Fiscal 2017
DECEMBER 21, 2017

Microbix Reports Full Year and Fourth Quarter Results – Record Sales of $10.2 Million Achieved for Fiscal 2017

DECEMBER 21, 2017 Angus Gastle

TORONTO, December 21, 2017 – Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, reports financial r...

Read more
Microbix Confirms Ramp-up of Production – Bioreactor Capacity Increasing by 500%
NOVEMBER 27, 2017

Microbix Confirms Ramp-up of Production – Bioreactor Capacity Increasing by 500%

NOVEMBER 27, 2017 Angus Gastle

TORONTO, November 27, 2017 – Microbix Biosystems Inc. (TSX: MBX), a developer and marketer of biological products and technologies, confirm...

Read more
Microbix Completes Second Tranche of Brokered Private Placement Tranche Gross Proceeds of $1,164,640, Total Proceeds of $3,500,000
OCTOBER 27, 2017

Microbix Completes Second Tranche of Brokered Private Placement Tranche Gross Proceeds of $1,164,640, Total Proceeds of $3,500,000

OCTOBER 27, 2017 Angus Gastle

TORONTO, October 27, 2017 – Microbix Biosystems Inc. (TSX: MBX) (“Microbix” or the “Company”), a developer and marketer of biological produ...

Read more
Microbix Completes Brokered Private Placement – Gross Proceeds of $2.3 Million
OCTOBER 19, 2017

Microbix Completes Brokered Private Placement – Gross Proceeds of $2.3 Million

OCTOBER 19, 2017 Angus Gastle

TORONTO, October 19, 2017 – Microbix Biosystems Inc. (TSX: MBX) (“Microbix” or the “Company”), a developer and marketer of biological produ...

Read more
Microbix Announces End of Legal Dispute – Allegations by ZeptoMetrix Withdrawn
OCTOBER 11, 2017

Microbix Announces End of Legal Dispute – Allegations by ZeptoMetrix Withdrawn

OCTOBER 11, 2017 Angus Gastle

TORONTO, October 11, 2017 – Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, is pleased to announ...

Read more
Microbix Announces First Shipment of Bioreactor Antigen
SEPTEMBER 13, 2017

Microbix Announces First Shipment of Bioreactor Antigen

SEPTEMBER 13, 2017 Angus Gastle

Customer Validation of New Manufacturing Process Completed TORONTO: September 13, 2017 – Microbix Biosystems Inc. (TSX: MBX), a developer ...

Read more
Microbix to Amend Share Purchase Warrant Terms
AUGUST 24, 2017

Microbix to Amend Share Purchase Warrant Terms

AUGUST 24, 2017 Angus Gastle

TORONTO August 24 2017 – Microbix Biosystems Inc. (TSX: MBX), a developer and marketer of biological products and technologies, announces i...

Read more
Microbix Reports Record Third Quarter & Nine Month Sales – Year-Over-Year Sales Growth Exceeding 20%
AUGUST 14, 2017

Microbix Reports Record Third Quarter & Nine Month Sales – Year-Over-Year Sales Growth Exceeding 20%

AUGUST 14, 2017 Angus Gastle

TORONTO, August 14, 2017 – Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today reports financi...

Read more

 

img

Added to cart successfully!